Annual report pursuant to Section 13 and 15(d)

Reconciliation of Net Income to Adjusted EBITDA (Detail)

v3.19.3.a.u2
Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 29, 2018
[4]
Nov. 28, 2017
[4]
Jun. 16, 2017
[4]
Dec. 31, 2019
[1]
Sep. 30, 2019
[1]
Jun. 30, 2019
[1]
Mar. 31, 2019
[1]
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]                            
Net income       $ 26,839 $ 31,955 $ 101,861 $ 33,193 $ 20,043 $ 50,621 $ 82,464 $ 62,177 $ 193,848 [1] $ 215,305 $ 266,019
Add (deduct):                            
Income taxes                       79,912 95,429 79,358
Interest expense [2],[3]                       99,941 109,994 105,918
Loss on debt amendments and refinancing $ 1,484 $ 331 $ 190                   1,484 521
Other income [5]                       (22,441) (18,472) (43,127)
Distributions and other cash distributions from equity investees                       53,366 30,143 25,973
Depreciation and amortization [2]                       261,155 261,162 237,513
Impairment of long-lived assets                       57,001 32,372 15,084
Loss on disposal of assets and other                       12,008 38,702 22,812
Non-cash rent expense [6]                       (4,360)    
Deferred lease expenses [2]                         (1,320) (1,268)
Amortization of long-term prepaid rents [2]                         2,382 2,274
Share based awards compensation expense                       14,615 14,336 12,681
Adjusted EBITDA [2],[7]                       745,045 781,517 723,758
Digital Cinema Implementation Partners                            
Add (deduct):                            
Distributions and other cash distributions from equity investees [8]                       23,696 5,799 5,864
Other Investees                            
Add (deduct):                            
Distributions and other cash distributions from equity investees [9]                       $ 29,670 $ 24,344 $ 20,109
[1] See Note 3 for discussion of the impact of ASC 842 that was effective January 1, 2019.
[2] Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[3] Includes amortization of debt issue costs.
[4] Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.
[5] Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM.
[6] The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives.  Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases.  See Note 3 for discussion of the impact of ASC Topic 842.
[7] Distributions from equity investees are reported entirely within the U.S. operating segment.
[8] See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 8.  These distributions are reported entirely within the U.S. operating segment.
[9] Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 7 and 8).  These distributions are reported entirely within the U.S. operating segment.